Oncotarget SARS-CoV-2 Spike Protein Disrupts p53 Tumor Suppressor Pathway In this new study, researchers investigated the interplay between the SARS-CoV-2 spike protein and tumor... read more May 9, 2024
Oncotarget Antitumor Effects of Sacituzumab Govitecan Plus Platinum-Based Chemotherapy In this study, researchers investigated the antitumor effects of Sacituzumab govitecan in combination with platinum-based... read more March 14, 2024
Oncotarget Biomarkers May Predict Neoadjuvant Chemosensitivity in Bladder Cancer In a new study, researchers aimed to identify and validate predictive biomarkers of response to... read more November 15, 2022
Oncotarget Synergy of HDACi, PARPi and Chemotherapeutics Against Blood Cancer Researchers investigated the efficacy of HDAC inhibitors in combination with PARP inhibitors and chemotherapeutic drugs... read more October 19, 2022
Oncotarget Trending With Impact: What Causes Chemo Brain? Researchers investigated potential therapeutic culprits of “chemo brain” in a trending new paper published by... read more January 28, 2022
Oncotarget Could Metformin and Rapamycin Replace Maintenance Chemotherapy? Researchers explored metformin with or without rapamycin as maintenance therapy in patients with metastatic pancreatic... read more December 16, 2021
Oncotarget New Study: ATR Inhibition Reverses Chemo-Resistance in Subset of Cells Ataxia telangiectasia and Rad3 (ATR) inhibition was targeted in an attempt to overcome temozolomide (TMZ)... read more October 13, 2021
Oncotarget New Study: How Exercise Boosted Chemotherapy in Mice A new study demonstrates how exercise impacts a highly-prescribed chemotherapeutic agent, doxorubicin, in murine models... read more September 1, 2021
Oncotarget Acid Reflux Drug Exhibits Anticancer Activity In the cover paper of Oncotarget's Volume 12, Issue 14, researchers repurposed an over-the-counter acid... read more July 7, 2021
Oncotarget Trending With Impact: Low-Dose Chemo Inhibits Resistant Breast Cancer In this trending in vitro study, researchers assessed the efficacy of low-dose 6-mercaptopurine and 5-azacitidine... read more June 17, 2021